ARTEMIS and Taconic Acquire Chemical Genetics Technology From CGI Pharmaceuticals, Inc.
Under the terms of the transaction, ARTEMIS and Taconic are assigned the entire portfolio of ASKA intellectual property rights (including all ASKA IP that CGI had previously licensed exclusively from Princeton University) as well as know-how, trade secrets and materials developed by CGI. Included are the rights to patents based on the chemistry and molecular biology work of Dr. Kevan Shokat, inventor of the ASKA technology. Financial details of the transaction were not disclosed.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.